// App-Quantinova.ai

602 : Whole-Genome Sequencing Reveals Evidence of Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Myeloma Precursor Disease

Researchers

Presenter

  • Bnedith Oben

Principal Investigators

  • Kylee H Maclachlan

  • Binbin Zheng-Lin

  • Venkata Yellapantula

  • Federico Abascal

  • Daniel A. Leongamornlert

  • Andriy Derkach

  • Ellen Geerdens

  • Benjamin Diamond

  • Ingrid Arijs

  • Brigitte Maes

  • Kimberly Vanhees

  • Malin Hultcrantz

  • Ahmet Dogan

  • Yanming Zhang

  • Aneta Mikulasova

  • Brian Walker

  • Gareth Morgan

  • Peter J Campbell

  • Ola Landgren

  • Jean-Luc Rummens

  • Niccolo Bolli

  • Francesco Maura

Medical Centers

  • Hasselt University, Hasselt, Belgium

  • Jessa Hospital, Hasselt, Belgium

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Wellcome Trust Sanger Institute, Cambridge, United Kingdom

  • Department of Biostatistics and Epidemiology, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Myeloma Service, Division of Hematologic Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY

  • VIB Center for Cancer Biology, Leuven, Belgium

  • University Biobank Limburg (UBiLim) and Clinical Biobank Jessa Hospital, Hasselt, Belgium

  • Department of Surgery, Gynecologic Service, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

  • Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom

  • Indiana University School of Medicine, Bloomington, IN

  • NYU Langone Health/NYU School of Medicine, New York, NY

  • Weill Cornell Medical College, New York, NY

  • Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy

  • Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy

Locations

  • Belgium

  • United States

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Multiple Myeloma

  • Monoclonal gammopathy

Biomarkers

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved